Study Data


MS Study

Project uploaded by: Yashwant
Project ID: IMP_100044
Title: (p)ppGpp and DksA play crucial role in reducing the efficacy of ꞵ-lactam antibiotics by modulating bacterial membrane permeability
Project Description: The key signaling molecules in the bacterial stress sensing pathway, the alarmone (p)ppGpp and transcription factor DksA, help in survival during nutritional deprivation and exposure to xenobiotics by modulating cellular metabolic pathways. In Vibrio cholerae, (p)ppGpp metabolism is solely linked with the functions of three proteins: RelA, SpoT, and RelV. At threshold or elevated concentrations of (p)ppGpp, the level of cellular metabolites and proteins in the presence and absence of DksA in V. cholerae and other bacteria has not yet been comprehensively studied. We engineered the genome of V. cholerae to develop DksA null mutants in the presence and absence of (p)ppGpp biosynthetic enzymes. We observed a higher sensitivity of the (p)ppGpp0ΔdksA V. cholerae mutant to different ꞵ-lactam antibiotics compared to the wild-type (WT) strain. Our whole-cell metabolomic and proteome analysis revealed that the cell membrane and peptidoglycan biosynthesis pathways are significantly altered in the (p)ppGpp0, ΔdksA, and (p)ppGpp0ΔdksA V. cholerae strains. Further, the mutant strains displayed enhanced inner and outer membrane permeability in comparison to the WT strains. These results directly correlate with the tolerance and survival of V. cholerae to ꞵ-lactam antibiotics. These findings may help in the development of adjuvants for ꞵ-lactam antibiotics by inhibiting the functions of stringent response modulators.
Research Area: Biological Sciences
Funding Source: Translational Research Program (TRP) (No. BT/PR30159/MED/15/188/2018) of Department of Biotechnology (DBT), Govt. of India.
Project Contributors: Yashwant Kumar

Study uploaded by: Yashwant
Study ID: IMS_100038
Title: (p)ppGpp and DksA play crucial role in reducing the efficacy of ꞵ-lactam antibiotics by modulating bacterial membrane permeability
Summary: The key signaling molecules in the bacterial stress sensing pathway, the alarmone (p)ppGpp and transcription factor DksA, help in survival during nutritional deprivation and exposure to xenobiotics by modulating cellular metabolic pathways. In Vibrio cholerae, (p)ppGpp metabolism is solely linked with the functions of three proteins: RelA, SpoT, and RelV. At threshold or elevated concentrations of (p)ppGpp, the level of cellular metabolites and proteins in the presence and absence of DksA in V. cholerae and other bacteria has not yet been comprehensively studied. We engineered the genome of V. cholerae to develop DksA null mutants in the presence and absence of (p)ppGpp biosynthetic enzymes. We observed a higher sensitivity of the (p)ppGpp0ΔdksA V. cholerae mutant to different ꞵ-lactam antibiotics compared to the wild-type (WT) strain. Our whole-cell metabolomic and proteome analysis revealed that the cell membrane and peptidoglycan biosynthesis pathways are significantly altered in the (p)ppGpp0, ΔdksA, and (p)ppGpp0ΔdksA V. cholerae strains. Further, the mutant strains displayed enhanced inner and outer membrane permeability in comparison to the WT strains. These results directly correlate with the tolerance and survival of V. cholerae to ꞵ-lactam antibiotics. These findings may help in the development of adjuvants for ꞵ-lactam antibiotics by inhibiting the functions of stringent response modulators.
Publication:
Release Date: Aug. 13, 2025
Study Type: Mass Spectrometry (MS)
Data Type: Untargeted
IEC/IBSC Approval Number :

Sr.No Sample ID Sample Name Organism Source Sample Preparation Protocol Sample Type Experimental Condition Time of treatment Variant/Variety Gender Age Replicates Storage Conditions Extraction Protocol Number of files per sample
71 IMSM_102121 N16_5 Vibrio cholerae | 666 Bacteria The cells were pelleted down again by centrifugation (10,000 rpm at 4°C for 10 min), washed with 0.9% normal saline and stored at -80°C. To extract the intracellular metabolites cold 100% methanol was added (Sigma Aldrich; Cat no. 34860) followed by vortexing and bath sonication for 10 min (Bransonic® Ultrasonic M Cleaning Bath 1510). The cell debris was pelleted down by centrifugation (10,000 rpm at 4°C for 10 min) and supernatant was collected in two separate microcentrifuge tubes (120 µL each tube), vacuum dried (Thermo Scientific™ Savant™ SPD1010) and stored at -80°C. For the analysis of metabolites, the dried supernatant was dissolved in 60 µL of 15% methanol or 50% acetonitrile (Cat no. 271004) followed by vortexing for 5 min and centrifuged (10,000 rpm for 10 min). The supernatant was collected in a separate sample vial (Supelco™ Analytical). wild type Untreated overnight at 37°C NA NA NA NA –80ºC

The cells were pelleted down again by centrifugation (10,000 rpm at 4°C for 10 min), washed with 0.9% normal saline and stored at -80°C. To extract the intracellular metabolites cold 100% methanol was added (Sigma Aldrich; Cat no. 34860) followed by vortexing and bath sonication for 10 min (Bransonic® Ultrasonic M Cleaning Bath 1510). The cell debris was pelleted down by centrifugation (10,000 rpm at 4°C for 10 min) and supernatant was collected in two separate microcentrifuge tubes (120 µL each tube), vacuum dried (Thermo Scientific™ Savant™ SPD1010) and stored at -80°C. For the analysis of metabolites, the dried supernatant was dissolved in 60 µL of 15% methanol or 50% acetonitrile (Cat no. 271004) followed by vortexing for 5 min and centrifuged (10,000 rpm for 10 min). The supernatant was collected in a separate sample vial (Supelco™ Analytical).

4
72 IMSM_102122 N16_6 Vibrio cholerae | 666 Bacteria The cells were pelleted down again by centrifugation (10,000 rpm at 4°C for 10 min), washed with 0.9% normal saline and stored at -80°C. To extract the intracellular metabolites cold 100% methanol was added (Sigma Aldrich; Cat no. 34860) followed by vortexing and bath sonication for 10 min (Bransonic® Ultrasonic M Cleaning Bath 1510). The cell debris was pelleted down by centrifugation (10,000 rpm at 4°C for 10 min) and supernatant was collected in two separate microcentrifuge tubes (120 µL each tube), vacuum dried (Thermo Scientific™ Savant™ SPD1010) and stored at -80°C. For the analysis of metabolites, the dried supernatant was dissolved in 60 µL of 15% methanol or 50% acetonitrile (Cat no. 271004) followed by vortexing for 5 min and centrifuged (10,000 rpm for 10 min). The supernatant was collected in a separate sample vial (Supelco™ Analytical). wild type Untreated overnight at 37°C NA NA NA NA –80ºC

The cells were pelleted down again by centrifugation (10,000 rpm at 4°C for 10 min), washed with 0.9% normal saline and stored at -80°C. To extract the intracellular metabolites cold 100% methanol was added (Sigma Aldrich; Cat no. 34860) followed by vortexing and bath sonication for 10 min (Bransonic® Ultrasonic M Cleaning Bath 1510). The cell debris was pelleted down by centrifugation (10,000 rpm at 4°C for 10 min) and supernatant was collected in two separate microcentrifuge tubes (120 µL each tube), vacuum dried (Thermo Scientific™ Savant™ SPD1010) and stored at -80°C. For the analysis of metabolites, the dried supernatant was dissolved in 60 µL of 15% methanol or 50% acetonitrile (Cat no. 271004) followed by vortexing for 5 min and centrifuged (10,000 rpm for 10 min). The supernatant was collected in a separate sample vial (Supelco™ Analytical).

4

Sr.No MS Exp ID Sample Name/ID Mass Spectrometer Type MS Instrument Name MS Instrument type MS Ionization Method Ion Mode/Scan Polarity Data Transformation (Software/s Used)
21 IME_101293 MC3_3 / IMSM_102083 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
22 IME_101294 MC3_4 / IMSM_102084 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
23 IME_101295 MC3_5 / IMSM_102085 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
24 IME_101296 MC3_6 / IMSM_102086 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
25 IME_101297 MC4_1 / IMSM_102087 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
26 IME_101298 MC4_2 / IMSM_102088 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
27 IME_101299 MC4_3 / IMSM_102089 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
28 IME_101300 MC4_4 / IMSM_102090 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
29 IME_101301 MC4_5 / IMSM_102091 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA
30 IME_101302 MC4_6 / IMSM_102092 LCMS (Liquid Chromatography- Mass Spectrometry) Thermo Fusion Orbitrap Orbitrap Electrospray Ionization - ESI Negative NA

Sr.No First name Last name Email Organization Designation
1 Yashwant Kumar y.kumar@thsti.res.in Translational Health Science And Technology Institute (THSTI) scientist

Sr.No ftprun ID MS Exp ID MS Data Files
131 IMR_102007 IME_101403 RP_POS_JV7_5.mzXML
132 IMR_102008 IME_101404 RP_POS_JV7_6.mzXML
133 IMR_102009 IME_101405 RP_POS_JV8_1.mzXML
134 IMR_102010 IME_101406 RP_POS_JV8_2.mzXML
135 IMR_102011 IME_101407 RP_POS_JV8_3.mzXML
136 IMR_102012 IME_101408 RP_POS_JV8_4.mzXML
137 IMR_102013 IME_101409 RP_POS_JV8_5.mzXML
138 IMR_102014 IME_101410 RP_POS_JV8_6.mzXML
139 IMR_102015 IME_101411 RP_POS_JV9_1.mzXML
140 IMR_102016 IME_101412 RP_POS_JV9_2.mzXML